Biotech | November 20, 2021
Novo Nordisk to acquire Dicerna Pharmaceuticals for US $ 3.3 bn
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
This is a shot in the arm for the vaccine manufacturers
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
It is used for the treatment of advanced colorectal and gastric cancer
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
Betting big on talent, resources, and the ecosystem required for innovation and enterprise, Prime Minister Narendra Modi invited stakeholders to ideate in India, innovate in India and Make in India for the world
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Subscribe To Our Newsletter & Stay Updated
